Mendota Financial Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-455
| Closed | -$62.1K | – | 278 |
|
|
2024
Q4 | $62.1K | Sell |
455
-195
| -30% | -$26.6K | 0.04% | 134 |
|
|
2024
Q3 | $74.9K | Hold |
650
| – | – | 0.04% | 141 |
|
|
2024
Q2 | $89.5K | Sell |
650
-100
| -13% | -$13.8K | 0.05% | 132 |
|
|
2024
Q1 | $103K | Sell |
750
-377
| -33% | -$52K | 0.06% | 125 |
|
|
2023
Q4 | $148K | Hold |
1,127
| – | – | 0.12% | 99 |
|
|
2023
Q3 | $127K | Hold |
1,127
| – | – | 0.13% | 73 |
|
|
2023
Q2 | $106K | Buy |
+1,127
| New | +$106K | 0.12% | 86 |
|